Thymosin Alpha-1 in the United States
FDA stated in December 2024 that products containing Thymosin Alpha-1 are not approved in the United States. The advisory committee voted 4 to 17 against placing both reviewed forms on the 503A Bulks List, and FDA currently identifies potential immunogenicity, impurity, and API-characterization concerns. These records do not authenticate a seller listing or decide every state pharmacy question.
- Evidence lane
- Research price board
- Global identity
- No FDA-approved US product; exact foreign prescription products exist